Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Jose Leclerc

Rangers Activate Jose Leclerc From Injured List

By | at

The Rangers announced they’ve reinstated reliever José Leclerc from the 60-day injured list. He’ll be active for tonight’s contest in Detroit, potentially setting him up for his first big league appearance in two years. Texas also activated reliever Brett Martin and outfielder Steele Walker from the COVID-19 IL. Walker and left-hander Kolby Allard have been optioned to Triple-A Round Rock to free active roster space. Tyson Miller, who’d been brought up as a designated COVID substitute, was taken off the 40-man roster and returned to the minors after two appearances.

Leclerc’s return is the biggest development for the Rangers, as it marks the end of a 15-month rehab process. The right-hander underwent Tommy John surgery just before Opening Day last year, costing him a season and a half worth of action. That came on the heels of a 2020 campaign in which he was limited to two appearances because of a shoulder strain, meaning he hasn’t seen extended action since 2019.

Before the health concerns threw his career off track, Leclerc looked as if he might emerge as one of the sport’s better late-inning arms. He’s shown swing-and-miss stuff throughout his career, but he was particularly effective in 2018. Leclerc posted a 1.56 ERA in 57 2/3 innings that season, striking out an elite 38.1% of opponents with a personal-low 11.2% walk rate. The following offseason, Texas signed him to a $14.75MM guarantee to buy out a pair of potential free agent seasons.

Leclerc’s control regressed in the first year of the deal, and he pitched to an underwhelming 4.33 ERA through 68 2/3 innings. Injuries have cost him the next two and a half seasons, but he’ll finally step back into the bullpen for skipper Chris Woodward. He tossed nine innings over as many appearances on a minor league rehab stint before returning to the MLB roster.

The 2022 season is the final guaranteed year of the aforementioned extension. Leclerc is making $5.25MM, and the club holds successive options for the next two seasons. They’ll have to decide on a $6MM option or a $750K buyout at the end of this year, making the next few months particularly critical for Leclerc’s long-term earning potential.

Rangers Trade Yonny Hernandez To Diamondbacks

By | at

The Rangers have set their Opening Day roster, announcing a series of transactions that includes the trade of infielder Yonny Hernandez to the Diamondbacks in exchange for minor league outfielder Jeferson Espinal. Arizona has designated right-hander Humberto Mejia for assignment in a corresponding roster move.

Texas also designated infielder Sherten Apostel for assignment and selected the contracts of veterans Matt Bush, Charlie Culberson and Greg Holland. Right-hander Garrett Richards, meanwhile, has been placed on the 10-day injured list due to a blister issue, while righty Jose Leclerc has been placed on the 60-day IL as he continues recovering from last March’s Tommy John surgery.

Hernandez, 24 next month, made his big league debut with Texas last year and batted .217/.315/.252 in 166 trips to the plate. His work in Triple-A, where he slashed .250/.424/.323 in 261 plate appearances, was far better. Hernandez walked at a gaudy 20.3% clip in Triple-A last season and has a penchant for drawing free passes and making contact, albeit rarely with any real power. He’s walked in more than 15% of his professional plate appearances and also possesses plenty of speed, evidenced by 23 steals in the minors and another 11 in the big leagues last season.

Hernandez has experience all over the infield and has all three minor league option years remaining, so he’ll give the D-backs some flexibility and versatility not only in 2022 but for the foreseeable future. He can be controlled for at least the next six seasons, and possibly more, depending on how much big league time he accrues while he has those options remaining.

Espinal, 19, batted a combined .259/.340/.357 between Rookie ball and Low-A last season, with the vast majority of his production coming at the lower of those two levels. Eric Longenhagen and Brendan Gawlowski wrote at FanGraphs back in January that Espinal has 70 speed on the 20-80 scale but a long swing and serious questions about his overall hitting profile. Espinal did swipe 16 bases in 19 tries last season, but he’ll have a ways to go before the Rangers can even hope to have him as a viable option in the outfield.

Apostel, 23, went 2-for-20 in his big league debut back in 2020 and didn’t appear in the Majors last season. He’s primarily a third baseman but has experience at first base as well. Apostel posted a lackluster .235/.321/.416 across three levels last season, topping out with a sub-par showing in Triple-A Round Rock. The Rangers will have a week to trade Apostel, place him on outright waivers or release him.

As for the D-backs, they’re in the same boat with regard to the 25-year-old Mejia. He’s tallied 32 1/3 big league innings but struggled to a 6.68 ERA in that time, and last year’s work in the minors was not decidedly more encouraging. In 103 2/3 frames between Double-A and Triple-A, Mejia pitched to a combined 5.12 ERA with a 22.1% strikeout rate and 8.2% walk rate. Another club in need of some pitching depth might take a look in a small trade or via waivers, but Mejia has not yet found too much success above A-ball.

8 Post-Tommy John Pitchers Who’ll Impact Next Year’s Market

By | at

We’ve grown accustomed to seeing headline after headline indicating that a pitcher is slated to undergo Tommy John surgery in today’s game. The procedure has become so commonplace, in fact, that it’s no longer surprising to see teams guarantee multi-year deals to rehabbing pitchers who’ll be sidelined for a full season of that contract as they work back from the injury. Such deals have produced varying levels of success in the past. Nathan Eovaldi’s two-year deal with the Rays worked out great; Drew Smyly didn’t pitch for the Cubs and posted a 6.24 after being traded to the Rangers.

Heading into the 2022 season, there are a handful of notable pitchers who were either signed under just that circumstance or are now playing for a contract on the heels of a Tommy John surgery that, hopefully, is more or less in the rearview mirror. A strong rebound will position any of this bunch either as a prominent member of next winter’s free-agent crop or, in some cases, to have a lucrative 2023 club option picked up. Here’s a look at a handful of Tommy John recoveries that could have a notable impact on next year’s market.

Starting Pitchers

Mike Clevinger: A marquee addition by the Padres at the 2020 trade deadline, Clevinger made only four regular-season starts and a one-inning postseason cameo before requiring Tommy John surgery in the 2020-21 offseason. San Diego, knowing he’d miss the entire 2021 season, signed him to a two-year, $11.5MM deal that paid him $2MM during his rehab season but will more heavily compensate him in 2022, now that he’s expected to be back to full strength. It was the second Tommy John procedure of Clevinger’s career, as he also had the surgery as a minor leaguer back in 2012.

There’s little questioning Clevinger’s talent, as the now-31-year-old righty was one of the most effective starters in all of baseball from 2017 until the time of his injury in 2020. In 489 1/3 innings over that stretch, Clevinger posted a 2.96 ERA while punching out 28% of his opponents against a 9% walk rate. Among big league pitchers with at least 400 innings thrown during that time, Clevinger ranked seventh in ERA and 14th in FIP (3.39). That said, he’s also only reached 130 innings in a big league season on one occasion, when he threw an even 200 frames in 2019.

That relatively limited workload, coupled with this being Clevinger’s second Tommy John procedure, will surely impact his free agency next winter to an extent. That said, a strong and healthy season out of the righty will still position him as one of the top arms on next winter’s market. Clevinger, teammate Joe Musgrove, Sean Manaea and Noah Syndergaard are among the more prominent free agents still in their early 30s next winter (to say nothing of older veterans with contract options or opt-outs, such as Jacob deGrom, Justin Verlander and Charlie Morton).

James Paxton: Paxton isn’t necessarily playing for a free-agent contract. He signed a complicated multi-year deal with the Red Sox that’ll pay him $6MM in 2022 before he can either trigger a $4MM player option or the team can exercise a pair of $13MM club options for the 2023-24 seasons. For luxury-tax purposes, that should be considered a two-year, $10MM deal, as the player option for 2023 is considered to be guaranteed money. Of course, there’s also the possibility that with a healthy season, the contract will effectively balloon to a contract that pays Paxton $32MM over a three-year term. The deal contains further incentives, as Paxton could boost those 2023-24 salaries by $250K apiece for reaching 12, 14, 16 and 18 starts.

It’s a heavily incentive-laden deal that speaks both to the considerable risk in signing Paxton and the considerable upside he’ll bring to Boston. A healthy Paxton is a high-quality big league starter, evidenced the career 3.50 ERA he carried into an injury-ruined 2020 season with the Yankees. Among the 149 big league starters to toss at least 200 innings from 2017-19, Paxton’s 30.1% strikeout rate ranked seventh, and his 7.3% walk rate was markedly better than league average. His 22.7 K-BB% was among the best in the game, as were his strong ratings in the eyes of fielding-independent metrics like FIP (3.26) and SIERA (3.45).

Since that 2019 season, however, Paxton has undergone back surgery, missed significant time with a forearm strain and eventually undergone Tommy John surgery. Earlier in his career, he’d dealt with lat, forearm and pectoral injuries, among a litany of smaller-scale issues.

There’s probably a scenario where Paxton pitches well enough to turn down his $4MM player option even if the Red Sox decline the effective two-year, $26MM option they hold over him. (We saw a comparable situation play out with Yusei Kikuchi earlier in the winter.) That said, the ideal scenario for Paxton and the Sox is that he pitches well enough to reestablish himself as a quality MLB hurler and boost those two club options to $14MM apiece in total value in the process.

Paxton underwent his Tommy John procedure in late April, so he’s not likely to be ready to help the Red Sox at the beginning of the season. By late May or June, however, he could represent a boost to a rotation that is not exactly shy of other injury concerns.

Justin Verlander: Even though he hasn’t pitched since undergoing Tommy John surgery, Verlander still got a hefty $25MM guarantee from the Astros — plus a conditional $25MM player option that kicks in if he reaches 130 innings pitched. The two-time Cy Young winner and former AL MVP has a track record that speaks for itself; when we last saw Verlander in a full, healthy season, he was edging then-teammate Gerrit Cole for the 2019 AL Cy Young Award.

Verlander has said in the past that he hopes to pitch into his 40s, and he has a good chance at doing so if he can bounce back this coming season. He’ll turn 39 later this week, and if he goes out and looks anything like he did from 2015-20 — 1010 innings, 2.94 ERA, 29.7% strikeout rate, 6% walk rate — Verlander will likely turn down that $25MM option, or at least leverage it into a new multi-year arrangement with the ’Stros. He was just promised a $25MM guarantee despite having thrown only six innings since Opening Day 2020, so there’s little reason to accept that he’d take a year and $25MM on the heels of a healthy return effort at Minute Maid Park.

Noah Syndergaard: Perhaps it’s not quite fair to label Syndergaard as a Tommy John rehabber; after all, he did make it back to the mound with the Mets late in the 2021 season — albeit for only two innings. That said, this is Thor’s first full season back from that ligament replacement procedure, and he’ll be pitching for a big contract next winter from the moment he suits up in Orange County. Signed by the Angels to a one-year, $21MM contract, Syndergaard will be pitching with a team other than the Mets for the first time in his big league career.

It’s a hefty price to pay, particularly considering the fact that Syndergaard had rejected an $18.4MM qualifying offer, but his career to date is all the evidence needed to suggest that at his best, Syndergaard is plenty worth that gamble. He’s never walked more than 6.1% of his opponents in a given season and has never failed to strike out a batter per inning. Few pitchers can match Syndergaard’s blend of pure velocity, missed bats and impeccable command, and he manages all that while still turning in a ground-ball rate that’s well higher than the league average.

Syndergaard has always felt like he’s one step away from solidifying himself as a bona fide ace, and as Robbie Ray showed in winning the AL Cy Young Award this season, one dominant season for a player with this type of track record can result in a nine-figure payday if things break right. The market has already proven to value Syndergaard at more than $20MM per year, and given that he’d be 30 years old in 2023, it’s not hyperbole to suggest that he’s pitching for a $100MM contract this season.

Luis Severino: As with Syndergaard, Severino may not quite fit the criteria for this list. The 27-year-old (28 later this week, on the same day Verlander turns 39) returned to give the Yankees six innings out of the bullpen late in the 2021 season, and his protracted absence from the team’s pitching staff cannot be solely attributed to Tommy John surgery. Severino has also battled groin, shoulder and lat injuries along the way. That said, Severino really hasn’t pitched since undergoing Tommy John surgery in Feb. 2020, and it’s that operation that is the primary reason for his absence over the past two seasons.

Severino isn’t yet slated to hit the open market at season’s end — at least not before the Yankees make a call on a $15MM club option or a $2.75MM buyout. The resulting $12.25MM net decision would be a straightforward one for general manager Brian Cashman if Severino at all looks like his former self. From 2017-18, Severino gave the Yankees 384 2/3 innings of 3.18 ERA ball with outstanding strikeout and walk rates, prompting the team to sign him to a four-year contract extension that promised him $40MM.

That deal looked like a bargain for the team at the time but has since gone south, due largely to repeated injury woes. Severino made a combined 63 regular-season starts for the Yankees in 2017-18, looking every bit like a foundational piece to the pitching staff, but he’s combined for just 25 starts and another 18 relief appearances in the five seasons surrounding that brilliant run.

With a big season in 2022, Severino could still see that $15MM option picked up, and if he can remain healthy into 2023, he’d hit the open market heading into his age-30 season. There’s a long way to go before that scenario becomes reality, however.

Relievers

Tommy Kahnle: Signed by the Dodgers to a two-year, $4.75MM contract last offseason, Kahnle was never expected to contribute in 2021 — hence the backloaded nature of his contract, which will pay him $3.45MM in 2022. The hard-throwing righty only managed one inning for the 2020 Yankees, meaning this coming season will be the first since 2019 in which he’ll potentially pitch anything resembling a full workload.

The 32-year-old Kahnle has been inconsistent but has dominated more often than he’s struggled. From 2016-20, he logged a combined 3.48 ERA, 32.9% strikeout rate and 9.9% walk rate while averaging 97.1 mph on his heater. That includes a disastrous but also fluky-looking 2018 campaign in which he was tattooed for a 6.56 ERA in 23 1/3 frames. From 2016-20, Kahnle’s 32.9% strikeout rate ranks 17th among the 155 relievers to have thrown at least 150 innings, while his 15.9% swinging-strike rate is tied for sixth.

Kahnle’s Tommy John surgery came way back on Aug. 5, 2020, so there should be no restrictions on him by the time the season gets underway. He’ll be heading into his age-33 season next winter, and a return to his vintage form should position him as one of the top relievers on a free-agent market that is lacking in big-name right-handed relievers.

Ken Giles: Like Kahnle, Giles was signed by the Mariners — two years, $7MM — knowing full well that he would not pitch in 2021. Unlike Kahnle, his contract includes a club option for the 2023 season, which is valued at $9.5MM (with a $500K buyout).

Many of the same superlatives that apply to Kahnle apply even more so to Giles. His 18% swinging-strike rate, for instance, tops Kahnle and sits third among the 155 relievers who totaled at least 150 frames from 2016-20. His 3.33 ERA in that time is a bit more toward the middle of the pack, but Giles misses bats, induces chases outside the zone and throws as hard as nearly any reliever in the sport. He’s had a pair of 4.00-something ERAs sprinkled in amid a series of pristine marks throughout his big league career. Those two blemishes have coincided with spikes in his average on balls in play and dips in his strand rate.

On the whole, Giles is a power arm who can pile up strikeouts in droves. He’s a sometimes forgotten piece of the puzzle when looking at the 2022 Mariners and their hopes of contending, but he’ll join a deep bullpen mix that also features Diego Castillo, 2021 breakout closer Paul Sewald, former Marlins stopped Drew Steckenrider (who enjoyed a tremendous rebound in 2021) and the underappreciated Casey Sadler, who notched a 0.67 ERA in 40 1/3 innings last year.

A healthy Giles would very likely see that $9.5MM club option for the 2023 season picked up, and at his best, he’s a bargain at that price. If Giles is pitching well but things go south for the Mariners, teams will come calling at the trade deadline. Of course, the Mariners are hoping to be squarely in the postseason mix, and they’re likely not done with their offseason shopping just yet.

Jose Leclerc: Armed with a fastball in the mid to upper 90s, Leclerc’s ability to return to form (or his lack thereof) will have major implications for the Rangers moving forward. His four-year, $14.75MM contract extension includes a $6MM club option for the 2023 season and a $6.25MM option for the 2024 season. A rebound effort makes that 2023 option a no-brainer for the Rangers to pick up as they hope to ride a hyper-aggressive offseason into their next competitive window.

Leclerc, 28, has fanned just shy of a third of the hitters he’s faced so far in his big league career and has only allowed a dozen homers in 189 Major League innings (0.57 HR/9). His 14.9% walk rate is far too high, but he looked to be making considerable strides in that department in 2019 when he posted a sub-2.00 ERA, a 38.1% strikeout rate and an 11.2% walk rate. He’ll be a highly intriguing lottery ticket on next year’s market if he pitches poorly enough that the Rangers buy that option out (or if they do so on the heels of another injury). If he rebounds, he’ll be a bargain piece of an on-the-rise Rangers club in 2023-24.

Jose Leclerc To Undergo Tommy John Surgery

By and | at

Rangers closer Jose Leclerc will undergo Tommy John surgery and miss the 2021 season, general manager Chris Young announced to reporters Monday (Twitter link via MLB.com’s Kennedi Landry).

Leclerc has battled elbow soreness since last week, so this news isn’t surprising, but it will rob him of an entire season and the Rangers of their best reliever. The 27-year-old threw just two innings last season as he dealt with a strain of his right teres muscle, and this latest injury will continue to throw a once-promising career off course.

Between 2016-19, Leclerc threw 187 innings of 3.16 ERA ball, and though he walked almost 15 percent of batters during that span, he helped offset that with a 33 percent strikeout rate and a fastball that averaged upward of 95 mph. The Rangers were so impressed with Leclerc’s work that they signed him to a four-year, $14.75MM extension before 2019. It looked like a worthwhile gamble at the time, but it hasn’t worked out as hoped for Texas because of Leclerc’s arm troubles. His deal still includes one more guaranteed season, in which he’s also sure to miss time as he recovers from this surgery, and two years with club options for $6MM or more or buyouts worth $750K or less apiece.

With Leclerc done for the season, it’s unclear who will open the season as the Rangers’ closer. Ian Kennedy and Matt Bush look like the most logical candidates, as they have game-ending experience and the Rangers selected their contracts over the weekend. Taylor Hearn and Josh Sborz are also among those who could be in the mix. Regardless, the loss of Leclerc is a significant one for the Rangers.

Jose Leclerc To Miss “Extended Time” With Elbow Soreness

By | at

Rangers closer Jose Leclerc is suffering from elbow soreness that will cause the righty to miss “extended time,” according to Evan Grant of the Dallas Morning News (Twitter link) and multiple reporters.  Leclerc has already left the Rangers’ Spring Training camp and headed to Texas for further examination.  In more unfortunate injury news, southpaws Joely Rodriguez and Brett Martin will also begin the season on the injured list, though their absences aren’t expected to last as long.

With Jonathan Hernandez already out through at least the first part of April due to a UCL sprain, Leclerc’s injury represents another long-term hit to the Texas bullpen.  Any mention of an elbow problem naturally raises the concern of Tommy John surgery, which would keep the 27-year-old Leclerc out of action until midway through the 2022 season.

This is the second significant injury in as many years for Leclerc, who pitched in only two games last season due to a tear of his right teres muscle.  His return to action was marked by a late arrival at camp due to visa issues, and then Leclerc didn’t have his usual velocity over 3 2/3 Cactus League outings, which perhaps isn’t unexpected as he was rebuilding his arm strength.

Despite it all, Leclerc was the provisional favorite to enter the season as the Texas closer.  He was first promoted to the job back in 2018, during a season that saw Leclerc post a 1.56 ERA/2.60 SIERA and a whopping 38.1K% (eighth-highest of any pitcher in baseball with at least 50 IP) over 57 2/3 frames out of the Rangers’ bullpen.  His performance took a step back in 2019, due in part to both an increase in walks and a big decrease in batted-ball luck (a .306 BABIP in 2019, as opposed to a .211 BABIP in 2018), but it should be noted that most of Leclerc’s struggles that year were contained to the month of April.

Prior to that 2019 season, Leclerc signed a contract extension that paid him a guaranteed $14.75MM through the 2022 season, with the Rangers holding club options on his services for both 2023 ($6MM, $750K buyout) and 2024 ($6.25MM, $500K buyout).  While not a huge financial investment, this extension will end up looking like something of a bust for Texas should the worst come to pass and Leclerc does require TJ surgery.

Rodriguez (sprained ankle) and Martin (back) haven’t yet pitched during Spring Training, but both left-handers could end up spending a relatively short time on the IL, perhaps even just a minimal 10-day absence.  Their returns will be greatly welcomed by a Rangers bullpen that is now suddenly thin on arms.  It remains to be seen who will be the first choice for save with both Leclerc and Hernandez out, and the role could fall to minor league signings Ian Kennedy or Matt Bush.

AL Notes: Rangers, Angels, Quatraro

By | at

Some notes from the American League:

  • The Rangers reinstated a trio of players from the 60-day injured list this afternoon, per a team announcement. Right-hander José Leclerc and left-handers Brock Burke and Joe Palumbo are all back on the 40-man roster, bringing Texas’ tally to 35. Those three relievers only combined for 4.1 innings in 2020. Leclerc suffered a teres major strain in July, while Burke underwent season-ending shoulder surgery in February. Palumbo, meanwhile, battled a bout of ulcerative colitis.
  • The Angels and assistant general manager Jonathan Strangio are parting ways, reports Fabian Ardaya of the Athletic (Twitter link). The Harvard alum’s contract expired October 31 and was not renewed. There’s been quite a bit of turnover in the Halos’ front office in recent weeks. The club fired general manager Billy Eppler, while former advisor Tony La Russa signed on as White Sox manager. As Ardaya notes in a follow-up tweet, Strangio had taken on a larger role in day-to-day baseball operations in the wake of Eppler’s firing. He informed the organization in August he’d be leaving at the end of the season for family reasons, Ardaya adds.
  • Before deciding on A.J. Hinch, the Tigers interviewed Rays bench coach Matt Quatraro in their managerial search, reports Marc Topkin of the Tampa Bay Times. Quatraro also drew some consideration from the Pirates and Giants for their respective vacancies last offseason. The 46-year-old has been on Kevin Cash’s coaching staff since the start of the 2018 season.

Kluber, Leclerc, Santana Won’t Return To Rangers This Season

By | at

SEPT. 9: Santana underwent elbow surgery and will miss seven to eight months, TR Sullivan of MLB.com tweets. That could jeopardize at least some of Santana’s 2021 campaign, which will be his final arbitration-eligible season. After Santana made a prorated $3.6MM this season, the Rangers will have to decide whether to keep him on the heels of a rough year.

SEPT. 5: Three injured Rangers players are done for the season, as manager Chris Woodward told reporters (including Evan Grant of the Dallas Morning News) that Corey Kluber, Jose Leclerc, and Danny Santana won’t return to action in 2020.  Kluber and Leclerc were each already on the 45-day injured list with teres major problems, while Santana has been on the 10-day IL since August 28 due to a right elbow strain.

The Rangers expected all three to be key contributors this season, hoping for a repeat of Santana’s breakout 2019 numbers, Leclerc to return to his 2018 form after a somewhat shaky 2019, and for Kluber to bounce back from an injured-plagued 2019 season that ultimately closed the book on the former ace’s tenure in Cleveland.

Instead, Kluber pitched in just one inning of one game for Texas before hitting the IL with a grade 2 tear of the teres major muscle.  Leclerc only banked two games before suffering a strain in his own teres major muscle, while Santana has been limited to 63 PA in 15 games (and only a .145/.238/.273 slash line) thanks to two trips to the injured list.  A right forearm strain put Santana on the 10-day IL on August 2 and kept him out of action until the middle of the month.

Leclerc is under contract through at least the 2022 season, while Santana has one more year of arbitration eligibility remaining before hitting free agency in the 2021-22 offseason.  Santana obviously won’t earn much of a raise on his $3.6MM salary for 2020, but given how the Rangers (like many teams) are planning on a lower payroll next season, it is conceivable that Santana could be non-tendered and then pursued at a lower price than a salary in the ballpark of $3.6 or $3.7MM.

Of course, a big chunk of money will be coming off the Rangers’ books in the form of Kluber’s contract, as Texas is surely unlikely to exercise its $18MM club option on the veteran righty for the 2021 campaign.  With just 36 2/3 total innings pitched since the start of the 2019 season, Kluber will be hard-pressed to find anything more than a single guaranteed year on his next contract, though his track record could still land him another Major League deal.  We aren’t far removed, after all, from the dominant five-year stretch Kluber delivered in the Indians’ rotation from 2014-18 — 2.85 ERA, 10.1 K/9, 5.51 K/BB rate, two AL Cy Young Awards, and an average of 218 innings pitched.

Rangers Place Jose Leclerc On 45-Day Injured List

By | at

5:40pm: The Rangers announced that Leclerc will be shut down for at least four weeks and will undergo platelet-rich plasma treatment later this week. He’s been placed on the 45-day injured list, which opens a spot on the 45-man roster.

5:05pm: Rangers closer Jose Leclerc has been diagnosed with a Grade 2 strain of the teres major in his right shoulder, the team announced to reporters (Twitter link via Jeff Wilson of the Fort Worth Star-Telegram). It’s the same diagnosis that recently sidelined Corey Kluber for the bulk of the 2020 season, though the club believes Leclerc’s injury to be a bit less severe. An exact timeline isn’t clear just yet, but Leclerc will miss a significant portion of the shortened 2020 season.

It’s not immediately cleae who’ll step into the ninth inning in Leclerc’s absence. Nick Goody got the call and converted a save last night with Leclerc unavailable, and he’s one of the more experienced arms in the Texas ’pen (despite being claimed off release waivers this winter). Veterans Jesse Chavez and Edinson Volquez are the only other relievers on the roster who have even two full years of Major League service time. A committee of sorts seems likeliest for now, although Goody’s perfect inning last night could give him the inside track if the Rangers opt to go with a set ninth-inning option.

Leclerc, 26, showed the ability to miss bats in bunches as a rookie in 2017 but demonstrated alarming control issues that year. In 2018, he looked to have put everything together, though, when he fired 57 2/3 frames of 1.56 ERA ball with 12 saves, 13.3 K/9 and 3.9 BB/9. That electric showing led the Rangers to sign him to a four-year, $14.75MM extension in March 2019. He stumbled out of the gates last year, but after a miserable month of April the flamethrowing righty pitched to a 3.57 ERA with 86 strikeouts against 30 walks in 58 frames.

The Rangers still have Leclerc signed through at least the 2022 season, and his contract contains affordable options for the 2023 and 2024 seasons: $6MM and $6.25MM, respectively. Leclerc is earning $2.25MM in 2020 (about $810K, prorated) and is guaranteed $4MM in 2021 and $4.75MM in 2022.

8 AL West Pitchers Looking For Bounce-Back Years

By | at

Our preseason series exploring potential bounce-back candidates for 2020 began with a look at several AL West hitters hoping to rebound. Let’s stay in the division and focus on a group of talented pitchers who want to put disappointing seasons behind them…

Corey Kluber, RHP, Rangers: Kluber was the Rangers’ highest-profile offseason pickup and someone who’s now near the front of a revamped rotation, but the Indians decided the 33-year-old was expendable in the wake of a truncated 2019. In a limited number of innings (35 2/3), Kluber came nowhere near his two-time Cy Young form, notching a 5.80 ERA/4.06 FIP, and didn’t pitch past May 1 as a result of a broken forearm. Kluber did strike out almost 10 batters per nine when he was healthy enough to take the mound, but he offset that with some of the worst walk (3.79 BB/9), groundball (40 percent) and average fastball velocity (91.6 mph) marks of his career. With the Rangers holding an $18MM option or a $1MM buyout over him for 2021, this is an especially pivotal season for Kluber.

Jose Leclerc, RHP, Rangers: Leclerc was an absolute force during a breakout 2018, but his run prevention numbers took noticeable steps backward because of control problems. He lost his job as the Rangers’ closer at one point early in the year and wound up with a 4.33 ERA and 5.11 BB/9 in 68 2/3 innings. However, the 26-year-old did get a lot better after a terrible May, and he also concluded with 13.11 K/9 and a career-high 96.8 mph average fastball velocity (1.5 mph better than he recorded during his dream ’18).

Andrew Heaney, LHP, Angels: Considering their lack of high-end pitching additions in the offseason, it’s particularly important for the the Angels to get a healthy and better version of Heaney in 2020. Injuries victimized Heaney last year, holding him to 95 1/3 innings of 4.91 ERA/4.63 FIP ball. He also struggled to induce grounders (33.6 percent), which helped lead to an 18.3 percent home run-to-fly ball rate. But Heaney did log 11.14 K/9 against 2.83 BB/9 with a personal-best average fastball velocity (92.5 mph) and a career-high swinging-strike rate (14.1 percent).

Lou Trivino, RHP, Athletics: Trivino had an outstanding rookie year from the A’s bullpen in 2018, but with the clear exception of his 97 mph-plus velocity, just about everything went downhill last season. Fewer strikeouts and more walks meant far more runs against, with Trivino’s ERA/FIP shooting from the twos and threes to 5.25/4.53 over 60 frames during a year that ended early because of rib issues. And Trivino wasn’t as lucky as he was a rookie, as his batting average on balls in play and strand rate each went the wrong way. On a more encouraging note, the 28-year-old did rank near the top of the majors in a few notable Statcast categories, including average exit velocity against (85.5 mph).

Joakim Soria, RHP, Athletics: Soria was another A’s reliever who may not have produced as the team hoped he would have in 2019. The A’s signed Soria to a two-year, $15MM deal in December 2018 after a terrific season between the White Sox and Brewers, but for the most part, he couldn’t match what he did then. That’s not to say Soria was bad – he still posted a 4.30 ERA/3.62 FIP with 10.3 K/9 and 2.61 BB/9, and his mean fastball velocity remained in the 93 mph range. Also, as with Trivino, Soria was something of a Statcast favorite, mostly earning good marks in that area.

Yusei Kikuchi, LHP, Mariners: On the heels of an excellent tenure in his homeland of Japan, Kikuchi was a high-profile signing for the Mariners entering the 2019 campaign. They guaranteed Kikuchi $56MM on a contract that could max out at $109MM, but Year 1 of the deal probably didn’t go to the Mariners’ liking. In his first season in the majors, the 28-year-old recorded a 5.46 ERA/5.71 FIP – both among the worst in the game – across 161 2/3 innings. He relied primarily on a fastball-slider-curve mix, but all three of those offerings ranked among the least effective of their kind, per FanGraphs. Kikuchi did walk fewer than three hitters per nine, though his K/9 (6.46) placed sixth from the bottom out of 75 pitchers who accumulated at least 150 innings.

Carl Edwards Jr., RHP, Mariners: It wasn’t long ago that Edwards was a key component of the Cubs’ bullpen. As recently as 2018, he put up a 2.60 ERA/2.93 FIP with 11.6 K/9 across 52 innings, though that stellar production did come in spite of a 5.54 BB/9 and a lowly 28.9 percent groundball rate. Edwards found a way to dodge home runs then, as he gave them up on just 3.8 percent of the many fly balls he allowed, but he wasn’t able to do so during an abbreviated, shoulder injury-plagued 2019 in the majors. Edwards only totaled 17 innings between the Cubs and Padres (his other 17 2/3 frames came in Triple-A ball), and he gave up HRs 15 percent of the time en route to an abysmal 8.47 ERA/5.74 FIP. His control got worse along the way, as he surrendered almost seven walks per nine, and so did his strikeout rate. Edwards fanned a little over 10 hitters per nine, but his strikeout percentage fell almost six points from the prior year, while his swinging-strike rate dropped nearly 4 percent. Still, for $950K, you can’t fault the Mariners for rolling the dice.

Yoshihisa Hirano, RHP, Mariners: Hirano’s another low-cost bullpen flier for the Mariners, whom they inked for $1.6MM last month. No doubt, they’re hoping they get a version of Hirano closer to 2018 than ’19. The former Diamondback recorded a 2.44 ERA/3.69 FIP in his first year in the majors, but those numbers rose to 4.75 and 4.04, respectively, last season. Hirano also generated fewer ground balls, gave up more home runs and issued more walks, though he did see his K percentage go up almost 4 percent, finishing with 10.36 per nine. Like the Edwards signing, there’s little to no harm from the M’s perspective in taking a chance on a rebound.

Rangers Notes: Globe Life Field, Rendon, Rodriguez

By | at

We’ll check in on some news coming out Arlington over the past 24 hours.

  • Globe Life Field, the new ballpark slated to open in 2020, caught fire yesterday afternoon (reported with video by Anthony Andro). Fortunately, no one was injured, relays Jeff Wilson of the Fort Worth Star-Telegram, who notes that the blaze was quickly contained by the Arlington Fire Department. A team spokesperson confirmed to Wilson that work will continue on the facility while an investigation into the fire’s cause is underway. Globe Life Field is slated to host its first exhibition game March 23. Texas’ regular-season home opener is March 31. Whether the incident will delay completion of the facility is not yet clear.
  • Texas put forth a six-year, $192MM offer to Anthony Rendon, which fell well shy of the seven-year, $245MM bid that wooed him to Anaheim. That figure, though, may not have been as high as Texas was willing to go for the superstar third baseman. The club viewed their $192MM proposal as a “starting point,” per Evan Grant of the Dallas Morning News, but Rendon’s camp seemingly never reengaged with them before he signed with the Angels. Whether and to what extent the Rangers would have gone further is unclear.
  • Having missed out on Rendon and seemingly not in play for Josh Donaldson, the Rangers may now pivot to the trade market to address holes on the roster, Grant further reports. Among those drawing interest from other teams are catching prospect Sam Huff and reliever Emmanuel Clase, in addition to the previously-reported José LeClerc.
  • Rendon pursuit notwithstanding, the Rangers didn’t come away from San Diego empty-handed. One executive tells the Athletic’s Peter Gammons (via Twitter) that Texas’ signing of left-handed reliever Joely Rodríguez to a two-year, $5MM deal was “the most underrated move of the Winter Meetings.” Rodríguez hasn’t had much success in affiliated ball, but he thrived in Japan, working to a 1.85 ERA with a 103:28 strikeout-to-walk ratio in 87.2 innings in NPB. Interestingly, Gammons notes that Rodríguez is now reportedly sporting a 97-99 MPH fastball. In his most recent MLB action, he averaged just 94.07 MPH on his four-seamer, per Brooks Baseball.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrowsFOX Sports Engage Network scroll to top